SIMSON JAKE received a stock award from JANUX THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/13/2026ACC: 0001863094-26-000002
+21K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
21K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5.50K
Price / share
—
Trade value
—
% of position
88.0%
6/11/2026
6.25K→11.75K
Total
Net shares
+5.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/11/2026 | A · Award | +5.50K | — | — | 88.0% | 6.25K | 11.75K |
| Total | +5.50K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
15.50K shares
Shares
+15.50K
Strike price
13.66
Held after
15.50K
Exercisable
—
6/11/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock15.50K shares | 6/11/2026 | A · Award | +15.50K | 13.66 | — | 15.50K |